Literature DB >> 21339364

α7-cholinergic receptor mediates vagal induction of splenic norepinephrine.

Gergely Vida1, Geber Peña, Edwin A Deitch, Luis Ulloa.   

Abstract

Classically, sympathetic and parasympathetic systems act in opposition to maintain the physiological homeostasis. In this article, we report that both systems work together to restrain systemic inflammation in life-threatening conditions such as sepsis. This study indicates that vagus nerve and cholinergic agonists activate the sympathetic noradrenergic splenic nerve to control systemic inflammation. Unlike adrenalectomy, splenectomy and splenic neurectomy prevent the anti-inflammatory potential of both the vagus nerve and cholinergic agonists, and abrogate their potential to induce splenic and plasma norepinephrine. Splenic nerve stimulation mimics vagal and cholinergic induction of norepinephrine and re-establishes neuromodulation in α7 nicotinic acetylcholine receptor (α7nAChR)-deficient animals. Thus, vagus nerve and cholinergic agonists inhibit systemic inflammation by activating the noradrenergic splenic nerve via the α7nAChR nicotinic receptors. α7nAChR represents a unique molecular link between the parasympathetic and sympathetic system to control inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339364      PMCID: PMC3083451          DOI: 10.4049/jimmunol.1003722

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  The vagus nerve and the nicotinic anti-inflammatory pathway.

Authors:  Luis Ulloa
Journal:  Nat Rev Drug Discov       Date:  2005-08       Impact factor: 84.694

2.  Coexpression and spatial association of nicotinic acetylcholine receptor subunits alpha7 and alpha10 in rat sympathetic neurons.

Authors:  Katrin Susanne Lips; Peter König; Katrin Schätzle; Uwe Pfeil; Gabriela Krasteva; Markus Spies; Rainer Viktor Haberberger; Sergei A Grando; Wolfgang Kummer
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Expression of nicotinic acetylcholine receptors on murine alveolar macrophages.

Authors:  Giovanni Galvis; Katrin Susanne Lips; Wolfgang Kummer
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.

Authors:  Esther M Sternberg
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

5.  Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia.

Authors:  Mauricio Rosas-Ballina; Mahendar Ochani; William R Parrish; Kanta Ochani; Yael T Harris; Jared M Huston; Sangeeta Chavan; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

6.  Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock.

Authors:  Domenica Altavilla; Salvatore Guarini; Alessandra Bitto; Chiara Mioni; Daniela Giuliani; Albertino Bigiani; Giovanni Squadrito; Letteria Minutoli; Francesco S Venuti; Francesco Messineo; Vincenzo De Meo; Carla Bazzani; Francesco Squadrito
Journal:  Shock       Date:  2006-05       Impact factor: 3.454

7.  The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice.

Authors:  David J van Westerloo; Ilona A Giebelen; Sandrine Florquin; Marco J Bruno; Gregory J Larosa; Luis Ulloa; Kevin J Tracey; T van der Poll
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

8.  Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling.

Authors:  William R Parrish; Mauricio Rosas-Ballina; Margot Gallowitsch-Puerta; Mahendar Ochani; Kanta Ochani; Li-Hong Yang; LaQueta Hudson; Xinchun Lin; Nirav Patel; Sarah M Johnson; Sangeeta Chavan; Richard S Goldstein; Christopher J Czura; Edmund J Miller; Yousef Al-Abed; Kevin J Tracey; Valentin A Pavlov
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

Review 9.  The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.

Authors:  W J de Jonge; L Ulloa
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

10.  Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis.

Authors:  Jared M Huston; Mahendar Ochani; Mauricio Rosas-Ballina; Hong Liao; Kanta Ochani; Valentin A Pavlov; Margot Gallowitsch-Puerta; Mala Ashok; Christopher J Czura; Brian Foxwell; Kevin J Tracey; Luis Ulloa
Journal:  J Exp Med       Date:  2006-06-19       Impact factor: 14.307

View more
  87 in total

Review 1.  Rethinking inflammation: neural circuits in the regulation of immunity.

Authors:  Peder S Olofsson; Mauricio Rosas-Ballina; Yaakov A Levine; Kevin J Tracey
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Exercise activates vagal induction of dopamine and attenuates systemic inflammation.

Authors:  Guilherme Shimojo; Biju Joseph; Roshan Shah; Fernanda M Consolim-Colombo; Kátia De Angelis; Luis Ulloa
Journal:  Brain Behav Immun       Date:  2018-10-27       Impact factor: 7.217

3.  Brain-Spleen Inflammatory Coupling: A Literature Review.

Authors:  J Rasouli; R Lekhraj; M Ozbalik; P Lalezari; D Casper
Journal:  Einstein J Biol Med       Date:  2011

4.  Vagal afferent activation suppresses systemic inflammation via the splanchnic anti-inflammatory pathway.

Authors:  Evilin Naname Komegae; David George Stephen Farmer; Virginia Leah Brooks; Michael Joseph McKinley; Robin Michael McAllen; Davide Martelli
Journal:  Brain Behav Immun       Date:  2018-06-05       Impact factor: 7.217

5.  From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis.

Authors:  Alexandre Kanashiro; Gabriel Shimizu Bassi; Fernando de Queiróz Cunha; Luis Ulloa
Journal:  Bioelectron Med (Lond)       Date:  2018-05

Review 6.  Cholinergic modulation of the immune system presents new approaches for treating inflammation.

Authors:  Donald B Hoover
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

7.  Nicotinic acetylcholine receptor expression and susceptibility to cholinergic immunomodulation in human monocytes of smoking individuals.

Authors:  Esmerij P van der Zanden; Francisca W Hilbers; Caroline Verseijden; Rene M van den Wijngaard; Mike Skynner; Kevin Lee; Luis Ulloa; Guy E Boeckxstaens; Wouter J de Jonge
Journal:  Neuroimmunomodulation       Date:  2012-03-21       Impact factor: 2.492

8.  NDP-MSH inhibits neutrophil migration through nicotinic and adrenergic receptors in experimental peritonitis.

Authors:  Jozi Figueiredo; Ana Elisa Ferreira; Rangel Leal Silva; Luis Ulloa; Paolo Grieco; Thiago Mattar Cunha; Sérgio Henrique Ferreira; Fernando de Queiróz Cunha; Alexandre Kanashiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-22       Impact factor: 3.000

9.  The anti-inflammatory potential of selective cholinergic agonists.

Authors:  Luis Ulloa
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

10.  Parasympathetic stimulation via the vagus nerve prevents systemic organ dysfunction by abrogating gut injury and lymph toxicity in trauma and hemorrhagic shock.

Authors:  Gal Levy; Jordan E Fishman; Dazhong Xu; Benjamin T J Chandler; Eleonora Feketova; Wei Dong; Yong Qin; Vamsi Alli; Luis Ulloa; Edwin A Deitch
Journal:  Shock       Date:  2013-01       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.